Neuropathy accompanying IgM lambda monoclonal gammopathy.

PubWeight™: 1.00‹?› | Rank: Top 15%

🔗 View Article (PMID 6306978)

Published in Acta Neuropathol on January 01, 1983

Authors

K Stefansson, L Marton, J P Antel, R L Wollmann, R P Roos, G Chejfec, B G Arnason

Articles cited by this

Electrophoretic analysis of the major polypeptides of the human erythrocyte membrane. Biochemistry (1971) 66.90

Naturally occurring antibodies against nine common antigens in human sera. I. Detection, isolation and characterization. J Immunol (1982) 4.21

Protein A, avidin, and biotin in immunohistochemistry. J Histochem Cytochem (1981) 2.30

Myelin-associated glycoprotein demonstrated immunocytochemically in myelin and myelin-forming cells of developing rat. Proc Natl Acad Sci U S A (1979) 1.97

Electron microscopic studies on ordinary and hyperacute experimental allergic encephalomyelitis. Acta Neuropathol (1967) 1.80

Myelin-associated glycoprotein is the antigen for a monoclonal IgM in polyneuropathy. J Neurochem (1982) 1.75

Plasma-cell dyscrasia and peripheral neuropathy with a monoclonal antibody to peripheral-nerve myelin. N Engl J Med (1980) 1.54

Waldenström's macroglobulinemia and neuropathy. Deposition of M-component on myelin sheaths. Neurology (1975) 1.47

Presence of the myelin-associated glycoprotein correlates with alterations in the periodicity of peripheral myelin. J Cell Biol (1982) 1.45

The neuropathy of multiple myeloma. J Neurol Neurosurg Psychiatry (1958) 1.44

Polyneuropathy in Waldenström's macroglobulinemia. Deposition of M component on myelin sheaths. Arch Neurol (1978) 1.35

Experimental allergic neuritis. Ultrastructure of serum-induced myelin aberrations in peripheral nervous system cultures. Lab Invest (1979) 1.12

Susceptibility of the myelin-associated glycoprotein and basic protein to a neutral protease in highly purified myelin from human and rat brain. J Neurochem (1982) 1.08

The initial structural lesion in serum-induced demyelination in vitro. Lab Invest (1976) 1.07

Plasma cell dyscrasia and peripheral neuropathy: identification of the myelin antigens that react with human paraproteins. Proc Natl Acad Sci U S A (1981) 1.05

Complement-fixing antiperipheral nerve myelin antibodies in patients with inflammatory polyneuritis and with polyneuropathy and paraproteinemia. Neurology (1981) 0.98

IgM-producing lymphocytes in peripheral nerve in a patient with benign monoclonal gammopathy. Scand J Haematol (1973) 0.93

Fine structural aspects of demyelination in vitro. The effects of Guillain-Barré serum. J Neuropathol Exp Neurol (1971) 0.90

Myeloma neuropathy: passive transfer from man to mouse. Science (1981) 0.88

The plasma cell dyscrasias: diverse presentations, pathophysiology, and management. Postgrad Med (1980) 0.79

Articles by these authors

Use of colonoscopy to screen asymptomatic adults for colorectal cancer. Veterans Affairs Cooperative Study Group 380. N Engl J Med (2000) 13.21

Long-term nonsurgical management of Barrett's esophagus with high-grade dysplasia. Gastroenterology (2001) 5.80

Amyotrophic lateral sclerosis and structural defects in Cu,Zn superoxide dismutase. Science (1993) 5.78

De novo CNV analysis implicates specific abnormalities of postsynaptic signalling complexes in the pathogenesis of schizophrenia. Mol Psychiatry (2011) 4.91

The inflammatory lesion in idiopathic polyneuritis. Its role in pathogenesis. Medicine (Baltimore) (1969) 4.72

Development of a multiple sclerosis functional composite as a clinical trial outcome measure. Brain (1999) 4.41

Molecular cloning and sequence determination of DA strain of Theiler's murine encephalomyelitis viruses. Virology (1988) 3.17

Neuroblastoma x spinal cord (NSC) hybrid cell lines resemble developing motor neurons. Dev Dyn (1992) 3.14

Evidence of axonal damage in the early stages of multiple sclerosis and its relevance to disability. Arch Neurol (2001) 2.75

Induction of tumour immunity with tumour cells treated with iodoacetate. Nature (1966) 2.42

Familial aggregation of Parkinson's disease in Iceland. N Engl J Med (2000) 2.41

The mutation rate in the human mtDNA control region. Am J Hum Genet (2000) 2.40

Recommendations for standardization and phenotype definitions in genetic studies of osteoarthritis: the TREAT-OA consortium. Osteoarthritis Cartilage (2010) 2.39

S-100 protein in soft-tissue tumors derived from Schwann cells and melanocytes. Am J Pathol (1982) 2.31

Copy number variations of chromosome 16p13.1 region associated with schizophrenia. Mol Psychiatry (2009) 2.29

Demyelinative myelopathy in mice induced by the DA virus. J Neurol Sci (1976) 2.20

Ethics of population genomics research. Nature (1999) 2.20

Neurovirulence determinants of genetically engineered Theiler viruses. Proc Natl Acad Sci U S A (1990) 2.15

Interferon-gamma-induced oligodendrocyte cell death: implications for the pathogenesis of multiple sclerosis. Mol Med (1995) 2.15

Gamma-sarcoglycan deficiency leads to muscle membrane defects and apoptosis independent of dystrophin. J Cell Biol (1998) 1.98

The genetic spectrum of a population-based sample of familial hemiplegic migraine. Brain (2006) 1.97

Axonal metabolic recovery in multiple sclerosis patients treated with interferon beta-1b. J Neurol (2001) 1.91

Association between the gene encoding 5-lipoxygenase-activating protein and stroke replicated in a Scottish population. Am J Hum Genet (2005) 1.91

Allelic frequencies and patterns of single-nucleotide polymorphisms in candidate genes for asthma and atopy in Iceland. Am J Respir Crit Care Med (2001) 1.89

Secretion of a nerve growth factor by primary chick fibroblast cultures. Science (1975) 1.88

Failure to detect enterovirus in the spinal cord of ALS patients using a sensitive RT-PCR method. Neurology (2004) 1.83

Surfactant-induced sealing of electropermeabilized skeletal muscle membranes in vivo. Proc Natl Acad Sci U S A (1992) 1.80

Alternative translation initiation site in the DA strain of Theiler's murine encephalomyelitis virus. J Virol (1991) 1.79

The importance of hiatal hernia in reflux esophagitis compared with lower esophageal sphincter pressure or smoking. J Clin Gastroenterol (1991) 1.77

Inositol stereoisomers stabilize an oligomeric aggregate of Alzheimer amyloid beta peptide and inhibit abeta -induced toxicity. J Biol Chem (2000) 1.76

Contribution of ADAM33 polymorphisms to the population risk of asthma. Thorax (2005) 1.76

Adenocarcinomas arising in tongues or short segments of Barrett's esophagus. Dig Dis Sci (1992) 1.71

Axonal damage correlates with disability in patients with relapsing-remitting multiple sclerosis. Results of a longitudinal magnetic resonance spectroscopy study. Brain (1998) 1.71

Brain-immune connection: immuno-regulatory properties of CNS-resident cells. Glia (2000) 1.70

The initial lesion in experimental allergic neuritis. A phase and electron microscopic study. J Exp Med (1968) 1.68

Imaging axonal damage of normal-appearing white matter in multiple sclerosis. Brain (1998) 1.68

Novel mutations in spastin gene and absence of correlation with age at onset of symptoms. Neurology (2000) 1.67

Synthesis of nerve growth factor by L and 3T3 cells in culture. Proc Natl Acad Sci U S A (1974) 1.64

Determination of contiguity of subclones using the polymerase chain reaction. Nucleic Acids Res (1988) 1.62

DA strain of Theiler's murine encephalomyelitis virus induces demyelination in nude mice. Ann Neurol (1984) 1.62

The leader peptide of Theiler's murine encephalomyelitis virus is a zinc-binding protein. J Virol (1995) 1.60

Population genomics: laying the groundwork for genetic disease modeling and targeting. Clin Chem Lab Med (1998) 1.59

The effect of short-term and chronic immunosuppression on Theiler's virus demyelination. J Neuroimmunol (1982) 1.57

Cell-specific proteins regulate viral RNA translation and virus-induced disease. EMBO J (2001) 1.56

Peripheral blood gamma-delta T cells lyse fresh human brain-derived oligodendrocytes. Ann Neurol (1991) 1.54

Strains from both Theiler's virus subgroups encode a determinant for demyelination. J Virol (1990) 1.53

Insights into the genetic architecture of osteoarthritis from stage 1 of the arcOGEN study. Ann Rheum Dis (2010) 1.53

Interferon-gamma-secreting cells in multiple sclerosis patients treated with interferon beta-1b. Neurology (1995) 1.53

Multiple sclerosis: Fas signaling in oligodendrocyte cell death. J Exp Med (1996) 1.53

Involvement of cardiovirus leader in host cell-restricted virus expression. Proc Natl Acad Sci U S A (1994) 1.52

Interferon beta-1b decreases the migration of T lymphocytes in vitro: effects on matrix metalloproteinase-9. Ann Neurol (1996) 1.51

The use of mitoxantrone (Novantrone) for the treatment of multiple sclerosis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology (2003) 1.49

Isoelectric focusing studies of serum and cerebrospinal fluid in patients with antecedent poliomyelitis. Ann Neurol (1989) 1.48

Fecal occult blood screening for colorectal cancer in a Veterans Administration Hospital. Am J Surg (1983) 1.47

Cytokine levels in the cerebrospinal fluid and serum of patients with multiple sclerosis. J Neuroimmunol (1991) 1.46

Inhibition of growth of established human glioma cell lines by modulators of the protein kinase-C system. J Neurosurg (1990) 1.46

Virus-induced abortion. Studies of equine herpesvirus 1 (abortion virus) in hamsters. Lab Invest (1975) 1.45

Neuroleukin: a lymphokine product of lectin-stimulated T cells. Science (1986) 1.44

Idiopathic polyneuritis after surgery. Arch Neurol (1968) 1.43

PK11195 binding to the peripheral benzodiazepine receptor as a marker of microglia activation in multiple sclerosis and experimental autoimmune encephalomyelitis. J Neurosci Res (1997) 1.43

Prospective serial analysis of interleukin-2 and soluble interleukin-2 receptor in relapsing-remitting multiple sclerosis. Neurology (1992) 1.42

Multiple sclerosis flares associated with recombinant granulocyte colony-stimulating factor. Neurology (2000) 1.42

Genetic factors contribute to the risk of developing endometriosis. Hum Reprod (2002) 1.42

A single amino acid change determines persistence of a chimeric Theiler's virus. J Virol (1994) 1.42

An alternatively spliced region of the human hexabrachion contains a repeat of potential N-glycosylation sites. Proc Natl Acad Sci U S A (1989) 1.41

Neutralizing monoclonal antibodies to Theiler's murine encephalomyelitis viruses. J Virol (1985) 1.41

Expanding the range of ZNF804A variants conferring risk of psychosis. Mol Psychiatry (2010) 1.41

Direct evidence of a role for amino acid 101 of VP-1 in central nervous system disease in Theiler's murine encephalomyelitis virus infection. J Virol (1991) 1.40

Concomitant chemoradiotherapy, neutron boost, and adjuvant chemotherapy for anaplastic astrocytoma and glioblastoma multiforme. Cancer Invest (1995) 1.39

AHPBA/AJCC consensus conference on staging of hepatocellular carcinoma: consensus statement. HPB (Oxford) (2003) 1.39

Multiple sclerosis: additional thoughts. J Neurol Sci (1992) 1.38

Distribution of S-100 protein outside the central nervous system. Brain Res (1982) 1.37

Characterization of a cell culture persistently infected with the DA strain of Theiler's murine encephalomyelitis virus. J Virol (1982) 1.37

Amyotrophic lateral sclerosis and life-sustaining therapy: patients' desires for information, participation in decision making, and life-sustaining therapy. Mayo Clin Proc (1991) 1.37

Cellular immunity in myasthenia gravis. Response to purified acetylcholine receptor and autologous thymocytes. N Engl J Med (1976) 1.36

Secretion of a nerve growth factor by mouse neuroblastoma cells in culture. Proc Natl Acad Sci U S A (1975) 1.36

Glial cell influence on the human blood-brain barrier. Glia (2001) 1.36

S-100 protein in human chondrocytes. Nature (1982) 1.35

Comparison of phenotypic and functional properties of immediately ex vivo and cultured human adult microglia. Glia (1996) 1.35

Interferon beta in multiple sclerosis. Neurology (1993) 1.35

Studies on the mechanism of action of nerve growth factor. Proc Natl Acad Sci U S A (1972) 1.32

Identification of a novel neuregulin 1 at-risk haplotype in Han schizophrenia Chinese patients, but no association with the Icelandic/Scottish risk haplotype. Mol Psychiatry (2004) 1.32

A protein critical for a Theiler's virus-induced immune system-mediated demyelinating disease has a cell type-specific antiapoptotic effect and a key role in virus persistence. J Virol (1998) 1.32

Trypsin-sensitive neutralization site on VP1 of Theiler's murine encephalomyelitis viruses. J Virol (1988) 1.31

A picornaviral protein synthesized out of frame with the polyprotein plays a key role in a virus-induced immune-mediated demyelinating disease. Nat Med (1995) 1.31

Relationship of Theiler's murine encephalomyelitis viruses to the cardiovirus genus of picornaviruses. Intervirology (1986) 1.30

Correlation of inflammatory infiltrate with the enlargement of experimental aortic aneurysms. J Vasc Surg (1992) 1.29

Isoelectric focusing of IgG eluted from multiple sclerosis and subacute sclerosing panencephalitis brains. Nature (1980) 1.28

Cell-mediated demyelination of peripheral nerve in tissue culture. Lab Invest (1969) 1.28

Barrett's oesophagus and colonic tumours. Lancet (1985) 1.28

Immunohistochemical and genetic evidence of myeloperoxidase involvement in multiple sclerosis. J Neuroimmunol (1997) 1.27

Gamma-interferon promotes proliferation of adult human astrocytes in vitro and reactive gliosis in the adult mouse brain in vivo. Proc Natl Acad Sci U S A (1991) 1.27

Experimental autonomic neuropathy: an immunologically induced disorder of reflex vasomotor function. J Neurol Neurosurg Psychiatry (1965) 1.26

Sharing of antigenic determinants between the nicotinic acetylcholine receptor and proteins in Escherichia coli, Proteus vulgaris, and Klebsiella pneumoniae. Possible role in the pathogenesis of myasthenia gravis. N Engl J Med (1985) 1.26